Cerebrolysin Ameliorates Performance Deficits, and Neuronal Damage in Apolipoprotein E-Deficient Mice

This publication has 17 references indexed in Scilit:

• Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE
  Brain Research, 1997
• Brain-derived peptides increase the expression of a blood-brain barrier GLUT1 glucose transporter reporter gene
  Neuroscience Letters, 1996
• Nerve growth factor and nootropic drug Cerebrolysin but not fibroblast growth factor can reduce spatial memory impairment elicited by fimbria-fornix transection: short-term study
  Neuroscience Letters, 1996
• Neurodegeneration in the Central Nervous System of apoE-Deficient Mice
  Experimental Neurology, 1995
• Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice
  Neuroscience Letters, 1995
• Brain-derived peptides regulate the steady state levels and increase stability of the blood-brain barrier GLUT1 glucose transporter mRNA
  Neuroscience Letters, 1995
• Synaptic loss in cognitively impaired aged rats is ameliorated by chronic human nerve growth factor infusion
  Neuroscience, 1995
• Effects of brain tissue hydrolysate on synaptic transmission in the hippocampus
  Pharmacology Biochemistry and Behavior, 1994
• Reactive synaptogenesis assessed by synaptophysin immunoreactivity is associated with GAP-43 in the dentate gyrus of the adult rat
  Experimental Neurology, 1991
• A multidimensional approach in testing nootropic drug effects (Cerebrolysin®)
  Archives of Gerontology and Geriatrics, 1990